Sustained Correction of Hereditary Antithrombin Deficiency in Mice by AAV8-Mediated Gene Delivery.

Saved in:
Bibliographic Details
Title: Sustained Correction of Hereditary Antithrombin Deficiency in Mice by AAV8-Mediated Gene Delivery.
Authors: Tao Y; Department of Hematology, West China Hospital, Sichuan University, Chengdu (Y.T.)., Lu H; Department of Hematology, West China Hospital, Sichuan University, Chengdu (Y.T.)., Wu T; Institute of Hematology, Union Hospital, Tongji Medical College (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Collaborative Innovation Center of Hematology (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Key Laboratory of Biological Targeted Therapies of the Chinese Ministry of Education, Wuhan (T.W., Y.C., J.G., Y.H., L.V.T.)., Cai Y; Institute of Hematology, Union Hospital, Tongji Medical College (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Collaborative Innovation Center of Hematology (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Key Laboratory of Biological Targeted Therapies of the Chinese Ministry of Education, Wuhan (T.W., Y.C., J.G., Y.H., L.V.T.)., Guo J; Institute of Hematology, Union Hospital, Tongji Medical College (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Collaborative Innovation Center of Hematology (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Key Laboratory of Biological Targeted Therapies of the Chinese Ministry of Education, Wuhan (T.W., Y.C., J.G., Y.H., L.V.T.)., Corral J; Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Spain (J.C.)., Hu Y; Institute of Hematology, Union Hospital, Tongji Medical College (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Collaborative Innovation Center of Hematology (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Key Laboratory of Biological Targeted Therapies of the Chinese Ministry of Education, Wuhan (T.W., Y.C., J.G., Y.H., L.V.T.)., Tang LV; Institute of Hematology, Union Hospital, Tongji Medical College (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Collaborative Innovation Center of Hematology (T.W., Y.C., J.G., Y.H., L.V.T.), Huazhong University of Science and Technology, Wuhan, China.; Key Laboratory of Biological Targeted Therapies of the Chinese Ministry of Education, Wuhan (T.W., Y.C., J.G., Y.H., L.V.T.).
Source: Arteriosclerosis, thrombosis, and vascular biology [Arterioscler Thromb Vasc Biol] 2026 Jul; Vol. 46 (7), pp. e324442. Date of Electronic Publication: 2026 May 28.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9505803 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4636 (Electronic) Linking ISSN: 10795642 NLM ISO Abbreviation: Arterioscler Thromb Vasc Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1524-4636
DOI:10.1161/ATVBAHA.126.324442